Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fuji
Chubb
AstraZeneca
Federal Trade Commission
QuintilesIMS
McKesson
McKinsey
Novartis
US Army

Generated: October 19, 2017

DrugPatentWatch Database Preview

ZOVIRAX Drug Profile

« Back to Dashboard

Which patents cover Zovirax, and when can generic versions of Zovirax launch?

Zovirax is a drug marketed by Glaxosmithkline, Valeant Bermuda, Mylan Pharms Inc, and VIB. and is included in six NDAs.

The generic ingredient in ZOVIRAX is acyclovir. There are fifty-five drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the acyclovir profile page.

Summary for Tradename: ZOVIRAX

US Patents:0
Applicants:4
NDAs:6
Suppliers / Packagers: see list6
Bulk Api Vendors: see list112
Clinical Trials: see list4
Patent Applications: see list7,865
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOVIRAX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-002Jun 29, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Vib
ZOVIRAX
acyclovir
CREAM;TOPICAL021478-001Dec 30, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Valeant Bermuda
ZOVIRAX
acyclovir
OINTMENT;TOPICAL018604-001Mar 29, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ZOVIRAX
acyclovir
TABLET;ORAL020089-001Apr 30, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-003Aug 30, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-001Oct 22, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ZOVIRAX
acyclovir
CAPSULE;ORAL018828-001Jan 25, 1985ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ZOVIRAX
acyclovir
SUSPENSION;ORAL019909-001Dec 22, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ZOVIRAX
acyclovir
TABLET;ORAL020089-002Apr 30, 1991ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZOVIRAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc
ZOVIRAX
acyclovir
TABLET;ORAL020089-001Apr 30, 1991► Subscribe► Subscribe
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-001Oct 22, 1982► Subscribe► Subscribe
Mylan Pharms Inc
ZOVIRAX
acyclovir
CAPSULE;ORAL018828-001Jan 25, 1985► Subscribe► Subscribe
Vib
ZOVIRAX
acyclovir
CREAM;TOPICAL021478-001Dec 30, 2002► Subscribe► Subscribe
Mylan Pharms Inc
ZOVIRAX
acyclovir
TABLET;ORAL020089-002Apr 30, 1991► Subscribe► Subscribe
Valeant Bermuda
ZOVIRAX
acyclovir
OINTMENT;TOPICAL018604-001Mar 29, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Moodys
Healthtrust
US Army
Argus Health
Mallinckrodt
Harvard Business School
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot